I'm sure this same was said for TLX in it's early years. CU6 clinical pipeline is maturing each step closer to commercialization is another step up in valuation and this doesn't include its expanding IP and other earlier stage products. Better than SOC read that out 10x.
I'm sure this same was said for TLX in it's early years. CU6...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.50 |
Change
0.110(4.60%) |
Mkt cap ! $789.2M | |||
| Open | High | Low | Value | Volume |
| $2.39 | $2.50 | $2.37 | $1.648M | 675.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 15791 | $2.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.50 | 74384 | 32 |
View Market Depth
| Last trade - 12.27pm 27/06/2025 (20 minute delay) ? |
| CU6 (ASX) Chart |